Neutral Sphingomyelinase and Breast Cancer Research
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Our understanding of the functions of neutral sphingomyelinase (N-SMase) signaling has advanced over the past decade. In this review, we focus on the roles and regulation of N-SMase 1, N-SMase 2, N-SMase 3, an enzyme that generates the bioactive lipid ceramide through the hydrolysis of the membrane lipid sphingomyelin. A large body of work has now implicated N-SMase 2 in a diverse set of cellular functions, physiological processes, and disease pathologies. We focus on different aspects of this enzyme's regulation from transcriptional, post-translational, and biochemical. Furthermore, we expected N-SMase involvement in cellular processes including inflammatory signaling, cell growth, apoptosis, and tumor necrosis factor which in turn play important roles in pathologies such as cancer metastasis, variable disease, and other organ system disorders. Lastly, we examine avenues where targeted N-SMase inhibition may be clinically beneficial in disease scenarios. (J Menopausal Med 2015;21:24-27)
Abstract
Our understanding of the functions of neutral sphingomyelinase (N-SMase) signaling has advanced over the past decade. In this review, we focus on the roles and regulation of N-SMase 1, N-SMase 2, N-SMase 3, an enzyme that generates the bioactive lipid ceramide through the hydrolysis of the membrane lipid sphingomyelin. A large body of work has now implicated N-SMase 2 in a diverse set of cellular functions, physiological processes, and disease pathologies. We focus on different aspects of this enzyme's regulation from transcriptional, post-translational, and biochemical. Furthermore, we expected N-SMase involvement in cellular processes including inflammatory signaling, cell growth, apoptosis, and tumor necrosis factor which in turn play important roles in pathologies such as cancer metastasis, variable disease, and other organ system disorders. Lastly, we examine avenues where targeted N-SMase inhibition may be clinically beneficial in disease scenarios. (J Menopausal Med 2015;21:24-27)
참고문헌 (27)
- Wu BX., "Mammalian neutral sphingomyelinases : regulation and roles in cell signaling responses", Neuromolecular Med, 12, pp.320~330 (2010)
- Hannun YA., "Many ceramides", J Biol Chem, 286, pp.27855~27862 (2011)
- Ogretmen B., "Biologically active sphingolipids in cancer pathogenesis and treatment", Nat Rev Cancer, 4, pp.604~616 (2004)
- 이은실, "Gail Model을 이용한 한국여성의 유방암 위험도 측정", 대한폐경학회지, 18(3), pp.180~186 (2012), 대한폐경학회
- 정재혁, "핵생검을 통한 양성 유방 병변의 맘모톰 절제에 대한 임 상적 연구", 대한폐경학회지, 19(1), pp.9~17 (2013), 대한폐경학회
- 손정빈, "호르몬 치료를 받은 한국 폐경 여성에서 발생한 유방암의 임상적 특성", 대한폐경학회지, 18(1), pp.52~59 (2012), 대한폐경학회[DOI]
- The Korean Society of Menopause Scientific Board., "Hormone replacement therapy and breast cancer in postmenopausal women", J Korean Soc Menopause, 17, pp.125~126 (2011)
- Tomiuk S., "Cloned mammalian neutral sphingomyelinase : functions in sphingolipid signaling?", Proc Natl Acad Sci U S A, 95, pp.3638~3643 (1998)
- Sawai H., "Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C", J Biol Chem, 274, pp.38131~38139 (1999)
- Krut O., "Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein", J Biol Chem, 281, pp.13784~13793 (2006)
- Clarke CJ., "Neutral sphingomyelinase 2(nSMase2)is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-alpha in MCF-7 cells", Biochem J, 435, pp.381~390 (2011)
- Corcoran CA., "Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies", Mol Cancer Res, 6, pp.795~807 (2008)
- Ito H., "Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer cell line, MCF-7", J Biochem, 151, pp.599~610 (2012)
- Ito H., "Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin", Biochim Biophys Acta, 1789, pp.681~690 (2009)
- Wu BX., "Identification and characterization of murine mitochondriaassociated neutral sphingomyelinase(MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5", J Biol Chem, 285, pp.17993~18002 (2010)
- Yabu T., "A novel mitochondrial sphingomyelinase in zebrafish cells", J Biol Chem, 284, pp.20349~20363 (2009)
- Mullen TD., "Ceramide and apoptosis : exploring the enigmatic connections between sphingolipid metabolism and programmed cell death", Anticancer Agents Med Chem, 12, pp.340~363 (2012)
- Petcoff DW., "Lipid levels in sperm, eggs, and during fertilization in Xenopus laevis", J Lipid Res, 49, pp.2365~2378 (2008)
- Luberto C., "Inhibition of tumor necrosis factorinduced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase", J Biol Chem, 277, pp.41128~41139 (2002)
- Canals D., "Drug targeting of sphingolipid metabolism : sphingomyelinases and ceramidases", Br J Pharmacol, 163, pp.694~712 (2011)
- Wiegmann K., "Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling", Cell, 78, pp.1005~1015 (1994)
- Ségui B., "Sphingolipids as modulators of cancer cell death : potential therapeutic targets", Biochim Biophys Acta, 1758, pp.2104~2120 (2006)
- Marchesini N., "Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism", J Biol Chem, 278, pp.13775~13783 (2003)
- Adam-Klages S., "FAN, a novel WDrepeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase", Cell, 86, pp.937~947 (1996)
- Adam-Klages S., "Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor", J Leukoc Biol, 63, pp.678~682 (1998)
- Belka C., "Tumor necrosis factor(TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase", EMBO J, 14, pp.1156~1165 (1995)
- Yang Z., "Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells", J Biol Chem, 268, pp.20520~20523 (1993)